Oxford Biodynamics Equity 2025

Oxford Biodynamics Aktienanalyse

What does Oxford Biodynamics do?

Oxford Biodynamics PLC is a company specialized in the development and application of epigenetic technologies. It was founded in 2007 in Oxford, United Kingdom and has since then had an impressive track record in researching and developing new methods for the detection and treatment of diseases. The business model of Oxford Biodynamics is to utilize its proprietary technology platform, EpiSwitch®, to offer validation and screening services to customers in the pharmaceutical and biotech industries. Oxford Biodynamics' technology platform utilizes epigenetic information to diagnose and predict diseases. The company also uses its technology to identify biomarkers that provide unique insights into the biological processes associated with specific diseases. Oxford Biodynamics operates in three main areas: diagnostics, research and development, and nanoparticle technology. In the diagnostics field, the company offers blood tests for early detection of breast cancer and other types of cancer. The tests utilize a combination of epigenetic signatures and artificial intelligence to deliver results. Oxford Biodynamics is also developing a test to aid in the diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's. In the research and development field, Oxford Biodynamics collaborates closely with pharmaceutical and biotech companies to identify epigenetic signatures specific to certain diseases. The company has already worked with major pharmaceutical companies to test the effectiveness of drugs in treating lung cancer and breast cancer. Oxford Biodynamics has also started a collaboration with the John Radcliffe Hospital in Oxford to develop new epigenetics-based methods for predicting premature births. In the nanoparticle technology field, the company utilizes its expertise in epigenetics to develop new technologies that enhance drug delivery and increase the therapeutic effects of medications. The company is currently developing a new type of nanoparticles specifically designed to target cancer cells. These nanoparticles are able to selectively concentrate on cancer cells and directly enter the targeted tissue, minimizing unwanted side effects and maximizing effectiveness. Overall, Oxford Biodynamics is a leading company in epigenetics research and technology development. The company has already made significant advancements in developing new diagnostic and therapeutic methods for various diseases and is constantly working to improve its technologies and expand its product range. The future of the company looks very promising as epigenetics becomes increasingly important in medical research and diagnostics, and Oxford Biodynamics is one of the leading companies in this field. Oxford Biodynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Oxford Biodynamics's Equity

Oxford Biodynamics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Oxford Biodynamics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Oxford Biodynamics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Oxford Biodynamics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Oxford Biodynamics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Oxford Biodynamics stock

What is the equity of Oxford Biodynamics this year?

Oxford Biodynamics has equity of 6.05 M GBP this year.

What was the equity of Oxford Biodynamics compared to the previous year?

The equity of Oxford Biodynamics has increased/decreased by 133.96% increased compared to the previous year.

What impact does a high equity have on investors of Oxford Biodynamics?

A high equity is advantageous for investors of Oxford Biodynamics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Oxford Biodynamics?

A low equity can be a risk for investors of Oxford Biodynamics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Oxford Biodynamics affect the company?

An increase in equity of Oxford Biodynamics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Oxford Biodynamics affect the company?

A reduction in equity of Oxford Biodynamics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Oxford Biodynamics?

Some factors that can affect the equity of Oxford Biodynamics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Oxford Biodynamics so important for investors?

The equity of Oxford Biodynamics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Oxford Biodynamics take to change the equity?

To change equity, Oxford Biodynamics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Oxford Biodynamics pay?

Over the past 12 months, Oxford Biodynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biodynamics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Oxford Biodynamics?

The current dividend yield of Oxford Biodynamics is .

When does Oxford Biodynamics pay dividends?

Oxford Biodynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oxford Biodynamics?

Oxford Biodynamics paid dividends every year for the past 0 years.

What is the dividend of Oxford Biodynamics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oxford Biodynamics located?

Oxford Biodynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oxford Biodynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oxford Biodynamics from 1/13/2025 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 1/13/2025.

When did Oxford Biodynamics pay the last dividend?

The last dividend was paid out on 1/13/2025.

What was the dividend of Oxford Biodynamics in the year 2024?

In the year 2024, Oxford Biodynamics distributed 0 GBP as dividends.

In which currency does Oxford Biodynamics pay out the dividend?

The dividends of Oxford Biodynamics are distributed in GBP.